We seek to invest in highly innovative technology and life sciences businesses
The Sands Capital Advantage
In growth equity, deal awareness is not a differentiator. The fastest-growing companies are relatively easy to identify. However, deal access is a differentiator. The most promising growth equity companies have highly competitive financing rounds where entrepreneurs choose partners.
We believe Sands Capital gains access to deals because we are recognized as an ideal partner for long-term growth.
Selectivity requires deep knowledge across the public and private markets, a repeatable process, valuation discipline, and conviction. We believe our six criteria framework instills the discipline to only invest in exceptional growth businesses at fair valuations.
We believe our processes and experience give us the conviction to work with the businesses that drive long-term returns.
Even the best businesses can benefit from strategic partners with business-model insight and deep domain knowledge. We seek to add value beyond financial support in the form of strategic and operational guidance, pre-IPO advice, and introductions focused on maximizing long-term opportunities.
We believe our focus and depth of resources enable us to positively impact long-term outcomes for both businesses and our investors.
Our global innovation strategy is at the nexus of our public and private strategies and seeks to invest in the best private technology business with the potential to become leading public companies.
Life Sciences Pulse
Our life sciences strategy seeks to invest in promising life sciences companies that we believe are at the heart of a technological and scientific revolution in healthcare.